Reply to 'Assessing the hepatitis C epidemiology in Switzerland: It's not that trivial'

doi:10.1111/jvh.13892

Comment

. 2024 Jan;31(1):53-56.

doi: 10.1111/jvh.13892. Epub 2023 Oct 7.

Reply to 'Assessing the hepatitis C epidemiology in Switzerland: It's not that trivial'

Barbara Bertisch^{1

2}, Christian Schaetti³, Patrick Schmid⁴, Laura Peter⁵, Pietro Vernazza⁶, Marc Isler⁷, Robert Oppliger⁷, Axel Jeremias Schmidt^{3

4

8}

Affiliations

¹ Checkin Zollhaus, Zürich, Switzerland.
² Institute of Global Health, University of Geneva, Geneva, Switzerland.
³ Communicable Diseases Division, Federal Office of Public Health, Bern, Switzerland.
⁴ Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
⁵ Department of International Relations, London School of Economics and Political Science, London, UK.
⁶ Infectious Disease Clinic, Poststrasse 2, St. Gallen, Switzerland.
⁷ Private Physician, Zürich, Switzerland.
⁸ Department of Public Health, Environments and Society, London School of Hygiene and Tropical Medicine, London, UK.

PMID: 37803995
DOI: 10.1111/jvh.13892

Comment

Reply to 'Assessing the hepatitis C epidemiology in Switzerland: It's not that trivial'

Barbara Bertisch et al. J Viral Hepat. 2024 Jan.

. 2024 Jan;31(1):53-56.

doi: 10.1111/jvh.13892. Epub 2023 Oct 7.

Authors

Barbara Bertisch^{1

2}, Christian Schaetti³, Patrick Schmid⁴, Laura Peter⁵, Pietro Vernazza⁶, Marc Isler⁷, Robert Oppliger⁷, Axel Jeremias Schmidt^{3

4

8}

Affiliations

¹ Checkin Zollhaus, Zürich, Switzerland.
² Institute of Global Health, University of Geneva, Geneva, Switzerland.
³ Communicable Diseases Division, Federal Office of Public Health, Bern, Switzerland.
⁴ Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
⁵ Department of International Relations, London School of Economics and Political Science, London, UK.
⁶ Infectious Disease Clinic, Poststrasse 2, St. Gallen, Switzerland.
⁷ Private Physician, Zürich, Switzerland.
⁸ Department of Public Health, Environments and Society, London School of Hygiene and Tropical Medicine, London, UK.

PMID: 37803995
DOI: 10.1111/jvh.13892

No abstract available

PubMed Disclaimer

Comment in

Response to "Reply to 'Assessing the hepatitis C epidemiology in Switzerland: It's not that trivial'".
Razavi H, Blach S, Bregenzer A, Bruggmann P, Cerny A, Maeschli B, Müllhaupt B, Negro F, Scheidegger C, Semela D. Razavi H, et al. J Viral Hepat. 2024 Jun;31(6):357-359. doi: 10.1111/jvh.13904. Epub 2023 Dec 8. J Viral Hepat. 2024. PMID: 38069467 No abstract available.

Comment on

Assessing the hepatitis C epidemiology in Switzerland: It's not that trivial.
Blach S, Bregenzer A, Bruggmann P, Cerny A, Maeschli B, Müllhaupt B, Negro F, Razavi H, Scheidegger C, Semela D. Blach S, et al. J Viral Hepat. 2024 Jan;31(1):51-52. doi: 10.1111/jvh.13879. Epub 2023 Aug 8. J Viral Hepat. 2024. PMID: 37551747 No abstract available.

References

REFERENCES

1. Blach S, Bregenzer A, Bruggmann P, et al. Assessing the hepatitis C epidemiology in Switzerland: it’s not that trivial. J Viral Hepat. 2024;31:51-52.
1. Bertisch B, Schaetti C, Schmid P, et al. Chronic hepatitis C virus infections in Switzerland in 2020: lower than expected and suggesting achievement of WHO elimination targets. J Viral Hepat. 2023;30:667-684. https://doi.org/10.1111/jvh.13842
1. Bihl F, Bruggmann P, Castro Batänjer E, et al. HCV disease burden and population segments in Switzerland. Liver Int off J Int Assoc Study Liver. 2022;42(2):330-339.
1. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144(10):705-714.
1. Agosti-Gonzalez R, Falcato L, Grischott T, Senn O, Bruggmann P. Hepatitis C antibody test frequencies and positive rates in Switzerland from 2007 to 2017: a retrospective longitudinal study. Swiss Med Wkly. 2023;153:40085.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information

[1] Blach S, Bregenzer A, Bruggmann P, et al. Assessing the hepatitis C epidemiology in Switzerland: it’s not that trivial. J Viral Hepat. 2024;31:51-52.

[2] Blach S, Bregenzer A, Bruggmann P, et al. Assessing the hepatitis C epidemiology in Switzerland: it’s not that trivial. J Viral Hepat. 2024;31:51-52.

[3] Bertisch B, Schaetti C, Schmid P, et al. Chronic hepatitis C virus infections in Switzerland in 2020: lower than expected and suggesting achievement of WHO elimination targets. J Viral Hepat. 2023;30:667-684. https://doi.org/10.1111/jvh.13842

[4] Bertisch B, Schaetti C, Schmid P, et al. Chronic hepatitis C virus infections in Switzerland in 2020: lower than expected and suggesting achievement of WHO elimination targets. J Viral Hepat. 2023;30:667-684. https://doi.org/10.1111/jvh.13842

[5] Bihl F, Bruggmann P, Castro Batänjer E, et al. HCV disease burden and population segments in Switzerland. Liver Int off J Int Assoc Study Liver. 2022;42(2):330-339.

[6] Bihl F, Bruggmann P, Castro Batänjer E, et al. HCV disease burden and population segments in Switzerland. Liver Int off J Int Assoc Study Liver. 2022;42(2):330-339.

[7] Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144(10):705-714.

[8] Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144(10):705-714.

[9] Agosti-Gonzalez R, Falcato L, Grischott T, Senn O, Bruggmann P. Hepatitis C antibody test frequencies and positive rates in Switzerland from 2007 to 2017: a retrospective longitudinal study. Swiss Med Wkly. 2023;153:40085.

[10] Agosti-Gonzalez R, Falcato L, Grischott T, Senn O, Bruggmann P. Hepatitis C antibody test frequencies and positive rates in Switzerland from 2007 to 2017: a retrospective longitudinal study. Swiss Med Wkly. 2023;153:40085.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reply to 'Assessing the hepatitis C epidemiology in Switzerland: It's not that trivial'

Affiliations

Reply to 'Assessing the hepatitis C epidemiology in Switzerland: It's not that trivial'

Authors

Affiliations

Comment in

Comment on

Similar articles

References

REFERENCES

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical